Live from the NIH registry
Studies recruiting near Lansing right now
Top 25 of 183 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Periprosthetic Joint Infection
Phase 2
Interventional 60 participants sought
University of Michigan Health - Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi)
· Sponsor: OsteoRemedies, LLC
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
UMH-Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi)
· Sponsor: Duke University
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
MSU Center for Bleeding and Clotting Disorders — Lansing, Michigan (1.3 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Lansing, Michigan (1.3 mi)
· Sponsor: Alkermes, Inc.
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Multiple Myeloma
Phase 2
Interventional 60 participants sought
KCI at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Phase 2
Interventional 102 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 600 participants sought
Advanced Rheumatology PC | Lansing, MI — Lansing, Michigan (1.3 mi)
· Sponsor: Takeda
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Lansing, Michigan (1.3 mi)
· Sponsor: Medtronic
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Novo Nordisk A/S
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
N/A - Healthy Subjects
N/A
Interventional 123 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Sparrow Cancer Center — Lansing, Michigan (1.3 mi)
· Sponsor: Agendia
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Sparrow Hospital — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma
Phase 3
Interventional 421 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Children's Oncology Group
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology